• Publications
  • Influence
Assessment of the infarct size in high-resolution electrocardiograms
There is the need for further investigations of the HR-OECG potential as a fast and accurate method for assessment of the AMI size and localization, and the discriminating ability of these OECG descriptors for recognition of the two studied AMI types is investigated. Expand
Early Left Ventricular Function Abnormalities in Obstructive Sleep Apnea
Tissue Doppler Imaging might be a reliable method for detection of early abnormalities in LV function in patients with OSA, even without overt diastolic or systolic LV dysfunction. Expand
Lipid-Lowering Potency and Tolerability of Generic Rosuvastatin in Bulgarian Patients with High and Very High Risk
The generic rosuvastatin ROSWERA® at dosage 10 mg and 20 mg daily demonstrated high lipidlowering efficacy and good safety profile in patients at high and very high cardiovascular risk. Expand
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
The baseline characteristics of patients in the RED‐HF trial, testing the hypothesis that anaemia correction with darbepoetin alfa will reduce the composite endpoint of death from any cause or hospital admission for worsening heart failure, and improve other outcomes, are described. Expand
Possibilities of signal-averaged orthogonal and vector electrocardiography for locating and size evaluation of acute myocardial infarction with ST-elevation.
SAECG may be useful for precise location of the site of the myocardial necrosis and assessment of the severity of impaired left ventricular systolic function of patients with ST-elevation myocardia infarct (STEMI) in the acute phase. Expand
Effects of Aliskiren on Blood Pressure and Myocardial Function Assessed by Global Longitudinal Strain in Patients with Arterial Hypertension and Diastolic Dysfunction
Adding aliskiren to combined antihypertensive therapy leads to significant improvement of hypertension control and myocardial function assessed by global longitudinal strain. Expand
Effects of the angiotensin receptor blocker Valsartan (Valsacor®) on arterial pressure, indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial
Valsartan (Valsacor®), used as an adjunct to the standard antihypertensive therapy in patients with insufficiently controlled AH, leads to optimisation of the AP values and improvement of the indices of diastolic and global myocardial function, with a very good safety profile. Expand